CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

NCT06355739 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

B Lymphocytic Leukemia
B Lymphoblastic Lymphoma

Interventions

DEVICE: CAR T cell injection

Sponsor

Zhu Xiaofan